(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

See omnystudio.com/listener for privacy information.